Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial

This multicentre, open-label, controlled clinical trial assessed the effects of epoetin alfa treatment on haematologic and quality of life (QOL) parameters in 182 anaemic (Hb⩽12 g dl(−1)) ovarian cancer patients receiving platinum chemotherapy. Patients were randomised 2 : 1 to receive epoetin alfa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkinson, P M, Antonopoulos, M, Lahousen, M, Lind, M, Kosmidis, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361228/
https://www.ncbi.nlm.nih.gov/pubmed/16570051
http://dx.doi.org/10.1038/sj.bjc.6603004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361228/
https://www.ncbi.nlm.nih.gov/pubmed/16570051
http://dx.doi.org/10.1038/sj.bjc.6603004

Ejemplares similares